Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

SCI Pharmtech Corp. (4119) Income Statement

SCI Pharmtech Corp. Income Statement

Last quarter (Q2 2026), SCI Pharmtech Corp.'s total revenue was NT$272.87M, a decrease of 26.55% from the same quarter last year. In Q2, SCI Pharmtech Corp.'s net income was NT$-12.85M. See SCI Pharmtech Corp.’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
NT$ 1.34BNT$ 1.52BNT$ 1.20BNT$ 899.74MNT$ 864.22M
NT$ 319.47MNT$ 410.67MNT$ 350.32MNT$ 291.18MNT$ 208.09M
NT$ 164.23MNT$ 212.38MNT$ 190.02MNT$ 172.21MNT$ 134.43M
Depreciation and AmortizationNT$ 252.97MNT$ 233.79MNT$ 145.29MNT$ 90.61MNT$ 63.71M
NT$ 408.21MNT$ 909.92MNT$ 515.77MNT$ 492.07MNT$ 142.81M
NT$ 155.25MNT$ 198.28MNT$ 160.30MNT$ 404.30MNT$ 63.30M
NT$ -53.05MNT$ 448.57MNT$ 203.89MNT$ 268.85MNT$ -8.15M
NT$ 102.19MNT$ 646.86MNT$ 364.19MNT$ 387.82MNT$ 65.51M
NT$ 107.37MNT$ 534.68MNT$ 294.72MNT$ 308.78MNT$ 55.70M
Per Share Metrics
Basic EPSNT$ 0.90NT$ 4.47NT$ 2.70NT$ 2.83NT$ 0.51
Diluted EPSNT$ 0.90NT$ 4.46NT$ 2.69NT$ 2.82NT$ 0.51
Weighted Average Shares Outstanding119.51M119.48M109.16M109.00M109.00M
Weighted Average Shares Outstanding (Diluted)119.79M119.95M109.61M109.33M109.21M

Currency in TWD

SCI Pharmtech Corp. Earnings and Revenue History

01B2B3B0 %15 %30 %45 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin